Kinathera
Pharmaceuticals - Marseille, Provence-Alpes-Côte d'Azur, France
Kinathera Employees
Kinathera Senior Management
Kinathera Details
Kinathera is a seed stage preclinical biotech on a mission to develop unique series of newly patented, orally delivered small chemical molecules to treat patients suffering from immuno-inflammatory disorders.Selective inhibition of our most advanced target, simultaneously: 1, blocks intracellular cascade of the ICOS receptor which control maturation of the humoral response and 2, inhibits type 1 interferon production, a master regulator of BAFF expression and demonstrated component of auto-immune diseases. Activity of Kinathera's compound on two key immune paths promises enhanced control of hyperactive immune reaction in auto immune or GvHD indications.
Kinathera Technologies
Load Balancers
Ubuntu
CMS
WordPress.org
Hosted Forms
Gravity Forms
Fonts
Typekit
Hosting
HostPapa
Online Video Platforms
YouTube